![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis |
Jinyue Yu, Peige Song, Rachel Perry, Chris Penfold, Ashley R. Cooper |
Diabetes Metab J. 2017;41(4):251-262. Published online August 22, 2017 DOI: https://doi.org/10.4093/dmj.2017.41.4.251 |
The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis Effects of green tea or green tea extract on insulin sensitivity and glycaemic control in populations at risk of type 2 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials Effect of green tea on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis Green tea extract lowers insulin resistance and triglyceride on type 2 diabetes patients with dyslipidemia: A randomized, double-blinded, and placebo controlled study Effect of green tea extract on lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study Metabolic Processes of Green Tea in Diabetes Mellitus Type 2 Green and black tea extract from Camellia sinensis does not improve glucose control in type 2 diabetes patients on diabetic medication Protective Effects of Catechins Isolate From GMB4 Clone Green Tea Against EPC In Type 2 Diabetes Mellitus Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study |